Create a baseline by calculating your average weight during the final week on semaglutide
It also mentions early clinical testing, though strong human data is still limited
Preliminary evaluation does not suggest a causal link
It is based on unverified, self-reported social media posts, which do not establish cause and effect and should not be treated as confirmation of new side effects." CLICK HERE TO DOWNLOAD THE FOX NEWS APP The company noted that the safety information for semaglutide is based on "rigorous clinical trials, regulatory review and ongoing monitoring." "Semaglutide has been extensively examined in robust clinical development programs, large real-world-evidence studies and has cumulatively over 49 million patient-years of exposure, and its safety and effectiveness are well understood."
By Michael Erman NEW YORK, Feb 19 (Reuters) - Online telehealth company Hims & Hers Health, seeking growth drivers as its original sexual-health franchises matured, may have overstepped with a risky launch of weight-loss pills that drew swift blowback from Danish drugmaker Novo Nordisk and U.S